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a-Endosulfan and P-endosulfan are isomers ofendosulfin, a pestiide used worldwide. In this
study, we examined thegenotoxicity ofa- andP-endosulfan in vitrowith a HepG2 cell line. We
usedsisterchromatidexch s (SCE), micronuclei (MN), and DNAstrandbreaks asdetected by
single-cell gel electrophoresis (SCG) assays as biomarkers to judge the genotoxicity ofa- and
P-endosulfan at concentrations from 1 x 10-12 M to 1 x 10-3 M. After treating HepG2 cdls for
48hrwithP-endosulfn, SCEshowed asignificant increase atconcentrations from 1 X 10-7 M to
1 x 10-5 M, and MN showed a significant increase at concentrations from 5 x 10-5 M to
1 x 10-3 M. a-Endosulfanfailed toshowsignificanteffect in boththe SCEandMN assays.After
treating HepG2 cells with a- or 13-endosulfan for l hr, DNA strand breaks were significantly
induced bya-endosulfan at concentrations fom 2 X 0o4 M to 1 x 10-3 M, and by,-endosulfn
at 1 x 10-3 M. The results ofthis study suggest that both a- and P-endosulfan are genotoxic to
HepG2 cells and that the genotoxicity ofP-endosulfan seems stronger than that ofa-endosulfan.
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Endosulfan is asynthetic chlorinated cyclodi-
ene that is an environmental endocrine dis-
ruptor (1). It was introduced into the earth's
environment in 1956 as a general use insecti-
cide, and it was primarily used to protect
food crops such as tea, fruits, vegetables, and
grains as well as wood from a wide variety of
insects and mites through contact poison.
Commercially used endosulfan is generally
composed of its two isomers-ca-endosulfan
and f3-endosulfan.
Endosulfan is toxic not only to insects,
but also to fish, animals, and humans (2,3).
Autopsy examinations have revealed its dam-
age to liver, lung, and brain (3). However,
the data regarding its genotoxicity (4), espe-
cially that of its two isomers, are limited.
Perhaps because its carcinogenicity and
genotoxicity have not been confirmed, endo-
sulfan is still widely used and continues to
pollute the human environment not only in
developing countries but in developed coun-
tries aswell (5).
In this study, we observed the influence
ofa- and ,B-endosulfan on the frequency of
sister chromatid exhanges (SCE), micronu-
dei (MN), and the DNAdamage assessed by
single-cell gel electrophoresis (SCG) in
HepG2, a target cell line that expresses estro-
gen receptors (6) and is able to metabolize
xenobiotics like S9 in vitro or in vivo (7).
Materials and Methods
Materials. All reagents used in this experi-
ment were ofanalytical grade.
We obtained a-endosulfan [a-1,4,
5,6,7,7-hexachlorbicyclo-(2.2.1)-5-hepten-
2,3-bis(methylen)sulfit; C9H6C1603S] from
Wako Pure Chemical Industries, Osaka,
Japan. We obtained P-endosulfan [P-
1,4,5,6,7,7-hexachlorbicyclo-(2.2.1)-5-hep-
ten-2,3-bis(methylen)sulfit; C9H6C1603S]
from Riedel-deHaen, Seelze, Germany. We
dissolved the endosulfans in DMSO (E.
Merck, Darmstadt, Germany) to prepare a
0.5-M stocksolution.
Cell culture. We obtained HepG2 cells
from the cell bank ofthe Institute ofPhysical
and Chemical Research ofJapan Wako-Shi,
Saitoma, Japan; cells were cultured in
Dulbecco's Modified Eagle's Medium
(Sigma, St. Louis, MO) containing 10% fetal
bovine serum (Biosciences PTY Ltd.,
Australia) and 1% penicillin-streptomycin
(Life Technologies, Grand Island, NY).
Before use, HepG2 cells were taken from
fluid nitrogen and washed 2 times with fresh
culture medium. After culturing for two pas-
sages in 37°C and 5% C02, we prepared the
HepG2 cells for use in the experiments.
SCE and MN. HepG2 cells (2 x 105)
were divided into 5 mL culture medium and
cultured for 48 hr. After discarding 2.5 mL
supernatant, we added 2.5 mL new culture
medium containing different concentrations
of either a- or f-endosulfan for both the
SCE and MN assays. We added 5-bromo-
2'-deoxyuridine (Sigma) in the SCE assay
(final concentration 40 pM). The cells were
cultured for another 48 hr. Six hours before
collection, we added colcemid (Sigma) to the
SCE assay (final concentration 2 x 10-7 M).
We used 0.2% DMSO as the vehicle control
and mitomycin C (Sigma) as the positive
control.
After 48-hr treatment in both SCE and
MN assays, we collected the HepG2 cells with
0.25% trypsin-EDTA (Life Technologies).
The cells were then treated with 0.075 M
KCI for 10 min and fixedwith Carnoy's solu-
tion (methanol:acetic acid 3:1, v/v) for 30
min. The cells were washed twice with
Carnoy's solution and stored in methanol
containing 1% (vlv) aceticacid.
For SCE measurement, we stained the
slides using the fluorescence-plus-Giemsa
differential staining method. We blindly
evaluated SCE in 30 cells per concentration
for each experiment. The final result was the
combination of two independent experi-
ments (n = 60 metaphases). For MN mea-
surement, we stained the slides with acridine
orange (40 pg/mL; Sigma) solution, and we
used the frequency of the micronucleated
cells per 1,000 HepG2 cells as the end point.
Wejudged the MN according to the fol-
lowing criteria: size (diameter one-tenth to
one-half of the main nucleus size), number
(< 3 MN/cell), number of nuclei (only one
main nucleus in the cells counted), attributes
(the micronudei must be round and have a
dear boundary), color (the micronudei must
have the same color and staining degree as
the main nucleus), separation (the micronu-
clei must be dearly separated from the main
nucleus), and location (the micronudei must
be in the same cell plasma with the main
nucleus).
To assess the effects of a- and ,-endo-
sulfan on the cell-cycle kinetics of the cells,
we scored the proliferation index (PI) on the
same slides used for counting SCE. We eval-
uated cell-cycle kinetics by the proportion of
the first (X1), second (X2), and third (X3) divi-
sion cells in 100 consecutive metaphases for
each independent experiment. We calculated
thePIaccording to thefollowingformula:
PI = (1 xX1) + (2 xX2) + (3x X3).
SCG. We divided 2 x 105 HepG2 cells
into 5 mLculture medium andcultured them
for 48 hr. After 2.5 mL supernatant was dis-
carded, we added 2.5 mL of a new culture
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medium containing different concentrations
of a- or ,-endosulfan. We used 2% DMSO
as the vehicle control. After 1 hroftreatment,
the cells were collected with 0.25% trypsin-
EDTA and adjusted to 1 x 106 cells/mL cell
suspension after thorough mixing. We mixed
25 pL cell suspension with 75 ,uL 0.75% low-
melting agarose (Nusieve GTG, FMC
BioProducts, Rockland, NY) and then placed
it on precleaned frosted micro slides
(Matsunami Glass Ind., LTD, Kishiwata,
Japan) that were first covered with 80 pL
0.5% normal-melting agarose (Sigma). To
make this layer adhere to the slide more effec-
tively, we used 20 pL 0.5% normal melting
agarose to cover the slide and dried it before-
hand. We immediately covered the mixed-cell
suspension with a coverglass, and then kept
the slides at 40C for 10 min to allow solidifi-
cation of the agarose. After gently removing
the coverglass, we covered the slides with a
thirdlayer oflow-melting agarose using a cov-
erglass, and then kept it at40C for another 10
min to allow solidification of the agarose.
After gently removing the coverglass, we
immersed the slides in a lysing solution for 1
hrand then moved them to theelectrophoret-
ic buffer to allow 20 min for the unwinding
of DNA strands, as described by Singh et al.
(8). The electrophoresis time was 20 min
under 25 V and 300 mA using an elec-
trophoresis compact power supply (ATTO
Corporation, Tokyo, Japan). After staining
with 20 pg/mL ethidium bromide (Sigma),
we measured the DNA strand breaks under a
fluorescent microscope using a DNA SCG
test system (Keio Electronic Ind. Co., Ltd,
Ibaraki, Japan). We examined all ofthe slides
5 hr after staining, and only the cells in the
central part ofthe slides were detected. In the
present study, we used the cell tail length to
represent the degree of DNA damage to the
HepG2 cells.
Statistics. We used Dunnett's test in
SPSS statistical software (SPSS, Inc.,
Chicago, IL) for the SCE and SCG assays.
We used the chi-square test in SPSS statisti-
cal software for the MN assay. For all three
assays, the results oftwo independent experi-
ments were combined for the analysis.
Results
Influence ofa- and f3-endosulfan on thefre-
quency ofSCE in HepG2 cells. We treated
HepG2 cells with concentrations of a- and
,-endosulfan ranging from 1 x 10-12 M to 1
x 10-5 M for 48 hr. Because HepG2 is an
aneuploid cell line (modal number = 55
chromosomes; range = 50-60 chromo-
somes), we calculated SCE per chromosome.
As shown in Table 1, P-endosulfan caused a
significant increase in SCE at concentrations
from 1 x 10-7 M to 1 x 10-5 M. In contrast,
a-endosulfan failed to show any significant
effect. SCE frequency was approximately
0.19/chromosome in 0.2% DMSO (vehicle
control) versus 0.27/chromosome in the
highest concentration (1 x 10-5 M) of
P-endosulfan. Positive controls treatedwith 1
x 10-7 M mitomycin C resulted in
0.484/chromosome (p < 0.01).
In these experiments, the addition of a-
and f-endosulfan did not cause any signifi-
cant change in the proliferation index as
compared to the cultures with the 0.2%
DMSO controls.
Influence ofa- and f3-endosulfan on the
frequency ofMN in HepG2 cells. We used
the frequency ofmicronucleated HepG2 cells
to represent the effects of a- and ,B-endosul-
fan on MN induction in the HepG2 cells. As
shown in Table 2, after treating HepG2 cells
for 48 hr with 1-endosulfan at concentra-
tions from 5 x 10-5 M to 1 x 10-3 M, the
frequency ofmicronucleated cells was signifi-
cantly increased; the frequency at 1 x 10-3 M
was approximately 6 times that of the con-
trol. Although we failed to find any signifi-
cant increase of MN in HepG2 cells treated
with oc-endosulfan, we found slight increases
in MN cells at higher concentrations (5 x
10-5 M to approximately 1 x 10-3 M). In the
present study, mitomycin C (1 x 10-6 M)
showed a much stronger potency to induce
MN (116 micronucleated cells in 2,000 cells)
than did ,B-endosulfan (p < 0.01).
Influence ofa- and 3-endosulfan on
induction ofDNA strandbreaks as evaluated
by SCG assay in HepG2 cells. We measured
the tail length of HepG2 cells treated with
Table 1. The effects ofa- and ,B-endosulfan on on the frequency ofSCEs in HepG2 cells.
a-Endosulfan I-Endosulfan
Concentration (M) No. SCEa PI SCEa PI
Control 60 0.206 ± 0.062 1.99 0.191 ± 0.085 2.02
1 x 1o-12 60 0.203 ± 0.078 2.00 0.200 ± 0.047 2.08
1 xio-11 60 0.216±0.068 2.00 0.204±0.058 2.01
1 x10-10 60 0.204±0.071 2.04 0.199±0.113 1.93
1 x O-9 60 0.204±0.076 2.00 0.196±0.075 1.99
1 x 10-8 60 0.206 ± 0.060 2.02 0.220 ± 0.070 2.01
1 x 10-7 60 0.197 ± 0.065 2.02 0.248 ± 0.080* 2.02
1 x 10-6 60 0.205 ± 0.053 1.91 0.252 ± 0.072** 1.97
1 x10-5 60 0.217±0.059 2.00 0.272±0.065** 1.93
aData are presented as mean ± SD. *Statistically significant as compared to control (Dunnett's test, p < 0.05).
**Statistically significant difference as compared to control(Dunnett's test, p< 0.01).
different concentrations of a- and P-endo-
sulfan. As shown in Table 3, after 1 hr treat-
ment, a-endosulfan induced significant
increases in DNA strand breaks at concen-
trations from 2 x 10-4 M to 1 x 10-3 M, as
did ,-endosulfan at 1 x 10-3 M.
Discussion
Endosulfan is an insecticide with estrogenic
activity that is toxic to many fish and
mammals. Some reports suggested that it
could accumulate in aquatic animals (S!) and
cause human fatalities (3). The genotoxicity
of its two isomers, however, has not been
confirmed.
To study the genotoxicity ofendosulfan,
we used HepG2 cells a) because endosulfan is
hepatoxic (3) and b) because the metabolic
property of human HepG2 cells will offer a
chance to examine the effects ofits metabo-
lites on those cells. The result will thus be
more comparable to findings in an in vivo
study. Finally, because the HepG2 cell line is
well reported in the genotoxic studies using
SCE, MN, and SCG assays (10,11), we
believe it is reasonable to use such cells to
examine thegenotoxicity ofendosulfan.
Our repeated in vitroexperiments showed
that both a- andP-endosulfan induced DNA
strand breaks as detected by SCG assay.
Nevertheless, HepG2 cells seem more sensi-
tive to a- than to [I-endosulfan, as shown by
the cell tail length. Because we used a dry-
layer gel technique on the slides, the three
layers of gel were easily prepared. Using
trypsin-EDTA to collect the HepG2 cells
kept the individual cells well separated and
evenlydistributed in the secondlayer ofgel.
For the SCE and MN assays, only P-
endosulfan showed significant effects on the
cell line, and our present results correspond
to the increased frequency of SCE in blood
lymphocytes from workers using pesticides
including endosulfan (12) and to the
increased SCE induced by endosulfan (1 x
10-6 M, mixture of a-endosulfan and ,B-
endosulfan) in human lymphoid cells (13).
The result ofMN induced by P-endosulfan
Table 2. Effects of a- and P-endosulfan on on the




1 x 10-7 18 14
1 x10-6 17 13
5 x 10-6 14 17
1 X 10-5 16 22
5x 10-5 26 39*
1X10-4 26 51*
5x 10-4 26 74*
1 x 10-3 30 82*
an= 2,000.bData representthe numberof HepG2 cellswith
at least one micronucleus. *Statistically significant as
compared to control (chi-square test, p<0.01).
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Table 3. The effect of a- and P-endosulfan on DNA strand breaks as detected bythe SCG assay in HepG2
cells.
Concentration a-Endosulfan 3-Endosulfan
(M) No. Tail length (pm)a No. Tail length (pm)a
Control 116 49.28± 16.57 123 40.26 ±8.26
2 x 10-5 119 54.73 ± 18.08 99 42.36± 7.31
1 X 10-4 110 53.37 ± 16.73 99 39.64 ±7.34
2 x 10-4 128 58.32 ± 16.08* 108 43.68 ±9.58
5x 10-4 118 60.13± 15.86* 90 44.33± 11.33
1 x10-3 108 63.56±32.73* 126 50.27±13.38*
Data are presented as mean ± SD. *Statistically significant as compared to control (Dunnett's test, p< 0.01).
is also in agreement with an in vivo study of
endosulfan (14).
In our present study, all three end points
were from two independent experiments,
and the results were sufficiently repeated.
Although both a- and I-endosulfan showed
genotoxicity to HepG2 cells at different con-
centrations by different end points, neither
ofthem showed any apparent effects on cell
cycle kinetics in the cell line.
Of the three biomarkers used in this
study, SCE and MN were more sensitive in
detecting the genotoxicity of ,-endosulfan,
but SCG was less sensitive. For a-endosulfan,
only SCG showed genotoxicities. The con-
centration ofa-endosulfan needed to induce
DNA strand breaks was apparently lower
than that of ,-endosulfan. Thus, our results
suggest that ,1-endosulfan more readily
induced SCE and MN, whereas a-endosulfan
more easily induced DNA strand breaks, as
detected bySCG in the HepG2 cells.
We have limited data regarding the
mechanisms ofthe genotoxicity ofa- and IB-
endosulfan. Clastogenic activity of the two
compounds and/or their metabolites may
exist, although only sparse data are available
so far (15,16). In addition, because spindle
poisoning is reported to relate to MN forma-
tions such as bisphenol and diethylstilbestrol
(17), whether ,-endosulfan actually induced
MN through spindle poisoning should be
examined in future studies.
Another possible target ofresearch might
be the estrogenic effects ofa- andP-endosul-
fan (18), given the existence of estrogen
receptors in HepG2 cells (154. Many environ-
mental estrogenic disruptors, such as diethyl-
stilbestrol, reportedly induce SCE either in
vitro or in vivo, and it seems that their effects
tend to be restricted to cells with abundant
estrogen receptors (20,21). Endosulfan (a
mixture of a- and f-endosulfan) is able to
combine with estrogen receptors and exert
biologic effects (22, and although we have
no direct evidence, it is difficult to exclude
the possibility that a- and 1-endosulfan bind
with the estrogen receptors in HepG2 cells
(19,23) to inducegenotoxicity in these cells.
Because a- and f3-endosulfan can be
metabolized by HepG2 cells, the genotoxici-
tywe found in the cell line mayindude their
metabolites. Further research is needed to
determine whether a- and ,B-endosulfan or
their metabolites are responsible for the
observed genotoxicity.
Our findings are based on a study using
a human hepatoma HepG2 cell line so as to
extrapolate the results to humans. However,
further studies with normal human cells and
human subjects exposed to the same agents
are needed.
In conclusion, the present study has
shown for the first time that both a- and f-
endosulfan aregenotoxic to HepG2 cells and
that the genotoxicity of ,B-endosulfan is
more potent than that of a-endosulfan.
Although the underlying mechanism is still
beyond our knowledge, the clastogenicity
and estrogenicity ofthe two isomers suggest
the need for further studies.
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